Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bio-Techne Cp Cmn (TECH) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 3,976,873
  • Shares Outstanding, K 37,310
  • Annual Sales, $ 499,020 K
  • Annual Income, $ 104,480 K
  • 36-Month Beta 0.73
  • Price/Sales 7.95
  • Price/Cash Flow 23.13
  • Price/Book 4.46

Price Performance

See More
Period Period Low Period High Performance
1-Month
95.68 +12.19%
on 02/07/17
107.38 -0.03%
on 02/27/17
+7.49 (+7.50%)
since 01/27/17
3-Month
95.68 +12.19%
on 02/07/17
109.36 -1.84%
on 12/09/16
+0.21 (+0.19%)
since 11/25/16
52-Week
85.34 +25.79%
on 03/01/16
117.42 -8.58%
on 07/08/16
+20.40 (+23.46%)
since 02/26/16

Most Recent Stories

More News
Implied Volatility Surging for Bio-Techne (TECH) Stock Options

Options traders are pricing in a big move for Bio-Techne (TECH) shares as it has huge implied volatility.

TECH : 107.22 (+0.59%)
Bio-Techne Named "Company of the Year" by Instrument Business Outlook

Bio-Techne has been named the 2016 Company of the Year by Instrument Business Outlook (IBO). IBO is the most authoritative newsletter for tracking developments in the analytical and life science instrumentation...

TECH : 107.22 (+0.59%)
Drug Stocks Reporting Earnings on Feb 7: GILD, MNK & More

Earnings growth turned positive in the last quarter and things are surely looking up as we stand in the middle of the earnings season.

TECH : 107.22 (+0.59%)
CELG : 121.48 (+2.75%)
USNA : 58.95 (+0.17%)
JNJ : 122.39 (-0.28%)
LLY : 83.14 (+0.33%)
GILD : 70.28 (+0.49%)
ABBV : 62.29 (+0.32%)
MNK : 54.66 (+2.40%)
PFE : 34.31 (+0.15%)
BIIB : 290.40 (+1.85%)
Bio-Techne To Host Conference Call On February 7, 2017 To Announce Second Quarter Financial Results

Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Tuesday, February 7, 2017, at 8:00 a.m. CST to review second quarter fiscal 2017 financial results.

TECH : 107.22 (+0.59%)
Bio-Techne Congratulates Astute Medical on Clinical Trial Results

In a major study released this weekend from the University Hospital Muenster, Germany1 (http://www.multivu.com/players/English/7899551-nephrocheck-test-acute-kidney-injury-outcomes/), Astute Medical's...

TECH : 107.22 (+0.59%)
Bio-Techne And Astute Medical Form Strategic Partnership

Bio-Techne Corporation (NASDAQ: TECH) today closed on a strategic equity investment in Astute Medical, Inc. (San Diego, CA), a diagnostic company devoted to improving patient healthcare outcomes through...

TECH : 107.22 (+0.59%)
ProteinSimple's Single-Cell Western platform named #1 on The Scientist's Top 10 Innovations of 2016

For nine years running, The Scientist has sought out recently released laboratory and research products that are making waves in life science laboratories. And for nine years, their expert panels of independent...

TECH : 107.22 (+0.59%)
Bio-Techne Declares Dividend

Bio-Techne Corporation (NASDAQ:TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended September 30, 2016. The quarterly dividend will be payable...

TECH : 107.22 (+0.59%)
Bio-Techne Releases First Quarter Fiscal 2017 Results

Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2016.

TECH : 107.22 (+0.59%)
Bio-Techne To Host Conference Call On October 31, 2016 To Announce First Quarter Financial Results

Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Monday, October 31, 2016, at 8:00 a.m. CDT to review first quarter fiscal 2017 financial results.

TECH : 107.22 (+0.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising...

See More

Support & Resistance

2nd Resistance Point 107.50
1st Resistance Point 107.05
Last Price 107.22
1st Support Level 105.77
2nd Support Level 104.94

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.